ABL80 FLEX CO-OX analyzer, model #393-841 (all software versions prior to 1.35). The ABL80 FLEX CO-OX is a portable, automated analyzer that measures pH, blood gases, electrolytes, glucose and oximetry in whole blood. The ABL80 FLEX CO-OX system is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point of care setting
Publicado el 14 de noviembre de 2012 · Inicio del retiro: 6 de enero de 2010
Resumen
FDA registra el retiro Z-0195-2013 de dispositivos médicos de Clase II, publicado el 14 de noviembre de 2012 e iniciado el 6 de enero de 2010. Empresa responsable: Sendx Medical Inc; Estado: Finalizado; Cantidad reportada: 767 units; Lote: Serial Numbers: all ABL80 FLEX CO-OX analyzers with sofware versions 1.30, 1.31, 1.32, 1.33, and 1.34. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The recall was initiated because SenDx Medical Inc. became aware of a software issue in the ABL80 FLEX CO-OX analyzer related to the reporting of the hemoglobin fractional parameters.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Sendx Medical Inc
- Distribuidor
- Worldwide Distribution-- US Distribution including the state of Ohio and the countries of Switzerland, Germany, France, Poland, Austria, Italy, Japan, Australia, Denmark, China, Sweden, Norway, Spain, United Kingdom, Netherlands, and Czech Republic.
- Lote
- Serial Numbers: all ABL80 FLEX CO-OX analyzers with sofware versions 1.30, 1.31, 1.32, 1.33, and 1.34.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDABoule Con-Diff Hematology Control 9 vials. For in vitro diagnostic use as a control to monitor the performance14 de noviembre de 2012
- FDAThe touchscreen display (model 94267) designed for use with the XPREZZON bedside monitor (model 91393) is14 de noviembre de 2012
- FDABoule Con Diff US Tri Pack, 6 Vials. For in vitro diagnostic use as a control to monitor the performance of14 de noviembre de 2012
- FDA"***Sharpoint IQ Geometry Slit Knife Angled, Bevel Up***Surgical Specialties Corporation Reading, PA***REF14 de noviembre de 2012
- FDACliniqa Liquid QCTM Cardiac Marker Control for i-STAT Level 1 (List Number 06F12-09; Lot Number 071039)14 de noviembre de 2012
- FDAABL80 FLEX (with FLEX software) and ABL80 FLEX CO-OX (with CO-OX software) - pH Blood Gas and Electrolytes5 de septiembre de 2012
Preguntas sobre este retiro
¿ABL80 FLEX CO-OX analyzer, model #393-841 (all software versions prior to 1.35). The ABL80 FLEX CO-OX is a portable, automated analyzer that measures pH, blood gases, electrolytes, glucose and oximetry in whole blood. The ABL80 FLEX CO-OX system is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or point of care setting fue retirado del mercado?
Sí. FDA publicó el retiro Z-0195-2013 el 14 de noviembre de 2012. Peligro reportado: The recall was initiated because SenDx Medical Inc. became aware of a software issue in the ABL80 FLEX CO-OX analyzer related to the reporting of the hemoglobin fractional parameters.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter